FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

426725002: Aliskiren (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2663054014 Aliskiren (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2675069014 Aliskiren en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2663054014 Aliskiren (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2663054014 Aliskiren (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2675069014 Aliskiren en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2675069014 Aliskiren en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
53811000195112 aliskiren it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
68751000195115 Aliskiren de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
789971000172114 aliskirène fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
789971000172114 aliskirène fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
53811000195112 aliskiren it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
68751000195115 Aliskiren de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aliskiren Is a Renin inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Aliskiren Is a Tetrazole (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Aliskiren Has disposition Renin inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Aliskiren Is a produit chimique catégorisé selon sa fonction false Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Aliskiren fumarate (substance) Is a False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept)
Product containing aliskiren (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing aliskiren and hydrochlorothiazide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept)
Aliskiren- and valsartan-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept)
Product containing aliskiren and amlodipine and hydrochlorothiazide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept)
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept)
Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has precise active ingredient False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Aliskiren- and valsartan-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing aliskiren in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Aliskiren- and hydrochlorothiazide-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has precise active ingredient False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet Has precise active ingredient False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has precise active ingredient False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has precise active ingredient False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has precise active ingredient False Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Aliskiren fumarate (substance) Is modification of (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept)
Aliskiren and hydrochlorothiazide only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only aliskiren and valsartan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only aliskiren and amlodipine and hydrochlorothiazide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only aliskiren (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only aliskiren and hydrochlorothiazide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only aliskiren and valsartan in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only aliskiren in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Aliskiren (as aliskiren fumarate) 150 mg oral tablet Has basis of strength substance (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 1
Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet Has basis of strength substance (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 3
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet Has basis of strength substance (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only aliskiren and amlodipine and hydrochlorothiazide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 3
Aliskiren- and amlodipine- and hydrochlorothiazide-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 3
Aliskiren (as aliskiren fumarate) 150 mg and hydrochlorothiazide 25 mg oral tablet Has basis of strength substance (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Aliskiren (as aliskiren fumarate) 300 mg and hydrochlorothiazide 25 mg oral tablet Has basis of strength substance (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2
Aliskiren (as aliskiren fumarate) 300 mg and valsartan 320 mg oral tablet Has basis of strength substance (attribute) True Aliskiren Inferred relationship Existential restriction modifier (core metadata concept) 2

This concept is not in any reference sets

Back to Start